# Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

> **NCT05584722** · — · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 150 (estimated)

## Conditions studied

- Idiopathic Pulmonary Arterial Hypertension
- Heritable Pulmonary Arterial Hypertension
- Unaffected Mutation Carriers: Healthy Participants With a Known BMPR2 Gene Mutation and Normal Pulmonary Pressure and RV Function on Echo
- Healthy Individuals With no Cardiopulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05584722
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584722, "Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT05584722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*